Summary
Precision oncology and personalized cancer treatment seek to tailor therapies to individual patients. However, translating drug testing results from patient-derived tumor samples to the clinic is hindered by inefficiencies due to inadequate models. This highlights the urgent...
More information & hyperlinks
Web resources: | http://intercellmed.nanotec.cnr.it |